An immunohistochemical study assessing factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to somatostatin analogues.
Phase of Trial: Phase IV
Latest Information Update: 30 May 2016
At a glance
- Drugs Pasireotide (Primary) ; Somatostatins
- Indications Acromegaly; Pituitary adenoma
- Focus Therapeutic Use
- 30 May 2016 New trial record